Jeff Yass’s Guardant Health GH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $33.7M | Buy |
224,300
+12,800
| +6% | +$1.39M | ﹤0.01% | 1905 |
|
|
2026
Q1 | $19.5M | Sell |
211,500
-744,700
| -78% | -$74.8M | ﹤0.01% | 2252 |
|
|
2025
Q4 | $97.7M | Buy |
956,200
+143,800
| +18% | +$12.9M | 0.01% | 907 |
|
|
2025
Q3 | $50.8M | Buy |
812,400
+212,000
| +35% | +$11.5M | 0.01% | 1332 |
|
|
2025
Q2 | $31.2M | Buy |
600,400
+57,000
| +10% | +$2.55M | ﹤0.01% | 1576 |
|
|
2025
Q1 | $23.1M | Buy |
543,400
+128,400
| +31% | +$5.54M | ﹤0.01% | 1614 |
|
|
2024
Q4 | $12.7M | Buy |
415,000
+320,700
| +340% | +$9.02M | ﹤0.01% | 2356 |
|
|
2024
Q3 | $2.16M | Sell |
94,300
-72,200
| -43% | -$2.04M | ﹤0.01% | 5121 |
|
|
2024
Q2 | $4.81M | Sell |
166,500
-159,100
| -49% | -$3.7M | ﹤0.01% | 3502 |
|
|
2024
Q1 | $6.72M | Buy |
325,600
+165,200
| +103% | +$3.54M | ﹤0.01% | 3181 |
|
|
2023
Q4 | $4.34M | Sell |
160,400
-60,400
| -27% | -$1.58M | ﹤0.01% | 3945 |
|
|
2023
Q3 | $6.54M | Sell |
220,800
-50,300
| -19% | -$1.77M | ﹤0.01% | 3117 |
|
|
2023
Q2 | $9.71M | Sell |
271,100
-56,400
| -17% | -$1.62M | ﹤0.01% | 2535 |
|
|
2023
Q1 | $7.68M | Sell |
327,500
-13,200
| -4% | -$377K | ﹤0.01% | 2833 |
|
|
2022
Q4 | $9.27M | Sell |
340,700
-19,800
| -5% | -$906K | ﹤0.01% | 2371 |
|
|
2022
Q3 | $19.4M | Buy |
360,500
+79,800
| +28% | +$4.1M | 0.01% | 1450 |
|
|
2022
Q2 | $11.3M | Buy |
280,700
+250,800
| +839% | +$12.4M | ﹤0.01% | 2042 |
|
|
2022
Q1 | $1.98M | Sell |
29,900
-108,400
| -78% | -$7.42M | ﹤0.01% | 5508 |
|
|
2021
Q4 | $13.8M | Buy |
138,300
+3,800
| +3% | +$393K | ﹤0.01% | 2280 |
|
|
2021
Q3 | $16.8M | Sell |
134,500
-25,200
| -16% | -$2.99M | ﹤0.01% | 2170 |
|
|
2021
Q2 | $19.8M | Sell |
159,700
-29,400
| -16% | -$3.95M | ﹤0.01% | 2046 |
|
|
2021
Q1 | $28.9M | Sell |
189,100
-2,400
| -1% | -$363K | ﹤0.01% | 1509 |
|
|
2020
Q4 | $24.7M | Sell |
191,500
-7,100
| -4% | -$817K | ﹤0.01% | 1515 |
|
|
2020
Q3 | $22.2M | Buy |
198,600
+78,600
| +66% | +$7.19M | ﹤0.01% | 1397 |
|
|
2020
Q2 | $9.74M | Sell |
120,000
-95,000
| -44% | -$7.65M | ﹤0.01% | 2168 |
|
|
2020
Q1 | $15M | Buy |
215,000
+116,700
| +119% | +$8.96M | ﹤0.01% | 1393 |
|
|
2019
Q4 | $7.68M | Sell |
98,300
-83,800
| -46% | -$6.04M | ﹤0.01% | 2399 |
|
|
2019
Q3 | $11.6M | Buy |
182,100
+46,400
| +34% | +$4.09M | ﹤0.01% | 1817 |
|
|
2019
Q2 | $11.7M | Buy |
135,700
+60,400
| +80% | +$4.61M | ﹤0.01% | 1736 |
|
|
2019
Q1 | $5.78M | Buy |
+75,300
| New | +$4.17M | ﹤0.01% | 2302 |
|
Other funds holding GH
DTC
Jeff Yass's GH Position: Q2 2026 in Review
Jeff Yass increased its Guardant Health (GH) stake by 748% in Q2 2026, buying an estimated $61.8M and bringing the position to 644,138 shares worth $96.6M. The position accounts for 0.01% of the portfolio, ranked #989.
Jeff Yass first reported a position in GH in Q1 2019 and has held it in 28 quarters since. 596 funds tracked by Wall St. Rank hold GH as of Q2 2026.
- Jeff Yass held 644,138 shares of Guardant Health worth $96.6M as of Q2 2026.
- Jeff Yass bought 568,149 Guardant Health shares in Q2 2026, an estimated $61.8M.
- Guardant Health made up 0.01% of Jeff Yass's portfolio in Q2 2026, its #989 holding.
- Jeff Yass first reported a position in Guardant Health in Q1 2019 and has held it in 28 quarters since.
- 596 funds tracked by Wall St. Rank held Guardant Health as of Q2 2026.
Based on Susquehanna International Group's 13F filing for Q2 2026, filed 14 Aug 2026.